002688.SZ深圳证券交易所 · 主板 Main
Jinhe Biotechnology 金河生物
Animal Health 动物保健Ⅱ
¥5.15−¥0.02 · −0.39%
Open 开盘
¥5.19
High 最高
¥5.21
Low 最低
¥5.13
Prev Close 昨收
¥5.17
Volume 成交量
476.4万股
Turnover 成交额
¥2,457.3万
Mkt Cap 总市值
¥43亿
P/E 市盈率
210.0×
Recent Activity 近期动态All Filings 全部公告 →
34 significant filings since 29 May 2026: 1 on share pledge, 15 on share issue and 9 on equity incentive, and 6 other kinds. The latest, on 24 Sep 2026: 关于回购注销部分限制性股票及注销公司回购专用证券账户库存股减少注册资本暨通知债权人的公告.
自 29 May 2026 起有 34 份重大公告：share pledge 1 份、share issue 15 份、equity incentive 9 份，另有 6 类。最新一份（24 Sep 2026）：关于回购注销部分限制性股票及注销公司回购专用证券账户库存股减少注册资本暨通知债权人的公告。
Price History 价格走势
5 sessions 个交易日, 18 Sep to 24 Sep 2026 · Live one-minute prices · High 最高 ¥5.31 · Low 最低 ¥5.12 · −0.39% on the previous close of ¥5.175.155.205.255.30
Volume 成交量
4,252
18 Sep21 Sep22 Sep23 Sep24 Sep
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Relative Value 同业比较
Animal Health 动物保健Ⅱ · 12 listed peers
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥43亿 | ¥39亿 | 5th highest of 12 · 12 家中第 5 高 | |
| Trailing P/E 市盈率 | 210.0x | 48.6x | 2nd highest of 9 · 9 家中第 2 高 | |
| P/B 市净率 | 1.7x | 2.1x | 5th lowest of 12 · 12 家中第 5 低 | |
| Revenue Growth 营收增速 | 4.1% | 0.0% | 5th highest of 12 · 12 家中第 5 高 | |
| Profit Growth 净利增速 | -5.1% | -36.2% | 4th highest of 12 · 12 家中第 4 高 | |
| Gross Margin 毛利率 | 37.8% | 38.8% | 6th lowest of 12 · 12 家中第 6 低 | |
| Net Margin 净利率 | 9.3% | 8.3% | 6th highest of 12 · 12 家中第 6 高 | |
| Return on Equity 净资产收益率 | 5.7% | 2.3% | 3rd highest of 12 · 12 家中第 3 高 | |
| Debt to Assets 资产负债率 | 56.1% | 23.4% | 2nd highest of 12 · 12 家中第 2 高 | |
| Grade Score 评级得分 | 56 | 54 | 5th highest of 12 · 12 家中第 5 高 |
Statement figures are for the period to 30 Jun 2026, filed by 12 of 12 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，12 家同业中 12 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
Largest Peers 主要同业
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Jinyu 生物股份 | ¥125亿 | 87.2x | 2.3x | 22.1% | 14.7% | 1.9% | C |
| Tianjin Ringpu Bio-Technology 瑞普生物 | ¥77亿 | 22.2x | 1.6x | 0.8% | 12.9% | 4.3% | C |
| China Animal Husbandry 中牧股份 | ¥68亿 | 48.6x | 1.2x | 13.5% | 2.3% | 0.9% | D |
| Keqian Biology 科前生物 | ¥57亿 | 18.1x | 1.4x | -23.3% | 30.7% | 2.8% | C |
| Jinhe Biotechnology 金河生物 | ¥43亿 | 210.0x | 1.7x | 4.1% | 9.3% | 5.7% | C |
| Wuhan HVSEN Biotechnology 回盛生物 | ¥42亿 | 12.3x | 1.8x | 5.2% | 23.9% | 9.1% | C |
| Pulike 普莱柯 | ¥35亿 | 24.1x | 1.4x | -12.2% | 13.0% | 3.0% | C |
| Lifecome Biochemistry 绿康生化 | ¥35亿 | — | 49.1x | -15.7% | 2.8% | 10.9% | C |
| Shen Lian Biomedical 申联生物 | ¥34亿 | — | 2.5x | -8.1% | -18.2% | -1.4% | D |
| Winsunbio 永顺生物 | ¥18亿 | 64.0x | 2.7x | -28.1% | 7.3% | 0.9% | D |
| Drive 驱动力 | ¥11亿 | 460.9x | 4.6x | -0.8% | -1.6% | -0.2% | D |
| Dayu Biological 大禹生物 | ¥6.96亿 | — | 2.9x | 15.7% | -36.9% | -10.6% | E |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。